Efficacy, safety and pharmacokinetics of a new 10% normal human immunoglobulin for intravenous infusion, BT595, in children and adults with primary immunodeficiency disease
Sign Up to like & getrecommendations! Published in 2022 at "Vox Sanguinis"
DOI: 10.1111/vox.13337
Abstract: To evaluate the efficacy, safety and pharmacokinetics of a new, highly purified 10% IVIg (BT595, Yimmugo®) administered in children and adults with Primary immunodeficiency diseases (PID). read more here.
Keywords: adults primary; safety pharmacokinetics; pharmacokinetics new; efficacy safety ... See more keywords
Risk factors for polypharmacy in older adults in a primary care setting: a cross-sectional study
Sign Up to like & getrecommendations! Published in 2018 at "Clinical Interventions in Aging"
DOI: 10.2147/cia.s176329
Abstract: Purpose Polypharmacy (PP) is a clinical challenge in older adults. Therefore, assessment of daily drug consumption (DDC) and its relationships is important. First-line health services have a crucial role in monitoring and preventing PP. In… read more here.
Keywords: adults primary; primary care; care setting; risk factors ... See more keywords
Allogeneic HSCT in Adolescents and Young Adults With Primary Immunodeficiencies
Sign Up to like & getrecommendations! Published in 2019 at "Frontiers in Pediatrics"
DOI: 10.3389/fped.2019.00437
Abstract: Significant advances in hematopoietic transplantation over the past 20 years, have facilitated the safe transplantation of older adults with higher co-morbidities. In pediatric practice these advances have simultaneously improved outcomes for sicker children with complex,… read more here.
Keywords: adults primary; adolescents young; hsct adolescents; primary immunodeficiencies ... See more keywords